The risk or severity of adverse effects can be increased when Perindopril is combined with Higenamine. Perindopril may increase the hypotensive activities of Cicletanine. The risk or severity of adverse effects can be increased when Perindopril is combined with Captopril. The serum concentration of Doxepin can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Reserpine is combined with Perindopril. Urapidil may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Choline magnesium trisalicylate. The risk or severity of adverse effects can be increased when Perindopril is combined with Resveratrol. The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Perindopril. The serum concentration of Brentuximab vedotin can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Fosinopril is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Celecoxib. Nitroaspirin may decrease the antihypertensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Apocynin. Perindopril may increase the orthostatic hypotensive activities of Duloxetine. The risk or severity of adverse effects can be increased when Perindopril is combined with Mizoribine. The serum concentration of Nefazodone can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Indoprofen. Aripiprazole may increase the hypotensive activities of Perindopril. Brimonidine may increase the antihypertensive activities of Perindopril. The risk or severity of adverse effects can be increased when Carbetocin is combined with Perindopril. The serum concentration of Mestranol can be decreased when it is combined with Perindopril. Perindopril may increase the hypotensive activities of Efonidipine. The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Perindopril. The risk or severity of adverse effects can be increased when Triamterene is combined with Perindopril. Phentolamine may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Bufexamac. The serum concentration of Conjugated estrogens can be decreased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Flurbiprofen. Latanoprost may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Pramipexole is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Serrapeptase. The risk or severity of adverse effects can be increased when Perindopril is combined with Parthenolide. The risk or severity of adverse effects can be increased when Perindopril is combined with Quinapril. The serum concentration of Sildenafil can be increased when it is combined with Perindopril. Molsidomine may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Labetalol is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Floctafenine. The risk or severity of adverse effects can be increased when Perindopril is combined with Naftifine. Piretanide may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Tinoridine. The risk or severity of adverse effects can be increased when Perindopril is combined with Meclofenamic acid. Safrazine may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Metipranolol. The risk or severity of adverse effects can be increased when Perindopril is combined with Cilazapril. The risk or severity of adverse effects can be increased when Perindopril is combined with E-6201. The risk or severity of adverse effects can be increased when Betaxolol is combined with Perindopril. Hydroflumethiazide may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Lornoxicam. The risk or severity of adverse effects can be increased when Perindopril is combined with Cyclophosphamide. The risk or severity of adverse effects can be increased when Perindopril is combined with Pethidine. The serum concentration of Ambroxol acefyllinate can be decreased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Kebuzone. Dihydralazine may increase the hypotensive activities of Perindopril. Nicorandil may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Valdecoxib. The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Perindopril. Pirlindole may increase the hypotensive activities of Perindopril. Nialamide may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Loxoprofen. The risk or severity of adverse effects can be increased when Perindopril is combined with Dinutuximab. The serum concentration of Cyclobenzaprine can be increased when it is combined with Perindopril. Perindopril may increase the hypotensive activities of Terlipressin. Perindopril may increase the nephrotoxic activities of Sodium phosphate. The risk or severity of adverse effects can be increased when Sufentanil is combined with Perindopril. The risk or severity of adverse effects can be increased when Nabilone is combined with Perindopril. The serum concentration of Lovastatin can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Bortezomib is combined with Perindopril. Perindopril may increase the hypotensive activities of Deserpidine. Pentoxifylline may increase the hypotensive activities of Perindopril. The serum concentration of Synthetic Conjugated Estrogens, A can be decreased when it is combined with Perindopril. Guanabenz may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Niflumic Acid. Amphetamine may increase the hypotensive activities of Perindopril. The serum concentration of Everolimus can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Bumetanide. The risk or severity of adverse effects can be increased when Trandolapril is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Naproxen. The risk or severity of adverse effects can be increased when Perindopril is combined with Alclofenac. The risk or severity of adverse effects can be increased when Doxazosin is combined with Perindopril. The risk or severity of adverse effects can be increased when Nicardipine is combined with Perindopril. The risk or severity of adverse effects can be increased when Telmisartan is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Nabumetone. The serum concentration of Afatinib can be increased when it is combined with Perindopril. The serum concentration of Delavirdine can be decreased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Timolol is combined with Perindopril. The metabolism of Perindopril can be increased when combined with St. John's Wort. The risk or severity of adverse effects can be increased when Perindopril is combined with PTC299. The serum concentration of Perindopril can be decreased when it is combined with Garlic. The risk or severity of adverse effects can be increased when Perindopril is combined with Indomethacin. Perindopril may increase the hypotensive activities of Bupranolol. The risk or severity of adverse effects can be increased when Perindopril is combined with Sulfasalazine. The serum concentration of Nortriptyline can be increased when it is combined with Perindopril. The metabolism of Diltiazem can be decreased when combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Hydralazine. The risk or severity of adverse effects can be increased when Perindopril is combined with Isosorbide Dinitrate. Perindopril may increase the hypotensive activities of Mibefradil. The risk or severity of adverse effects can be increased when Nisoldipine is combined with Perindopril. Candoxatril may increase the hypotensive activities of Perindopril. The serum concentration of Riociguat can be increased when it is combined with Perindopril. Diflunisal may decrease the antihypertensive activities of Perindopril. Isocarboxazid may increase the hypotensive activities of Perindopril. The therapeutic efficacy of Perindopril can be decreased when used in combination with Acemetacin. The risk or severity of adverse effects can be increased when Perindopril is combined with Iron. Rasagiline may increase the hypotensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Etanercept. The risk or severity of adverse effects can be increased when Perindopril is combined with Apremilast. Vardenafil may increase the antihypertensive activities of Perindopril. Acetylsalicylic acid may decrease the antihypertensive activities of Perindopril. The risk or severity of adverse effects can be increased when Clofarabine is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Isoxicam. Perindopril may increase the hypotensive activities of Zofenopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Rofecoxib. The risk or severity of adverse effects can be increased when Rotigotine is combined with Perindopril. The risk or severity of adverse effects can be increased when Conivaptan is combined with Perindopril. Mirodenafil may increase the antihypertensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Benoxaprofen. The risk or severity of adverse effects can be increased when Lisinopril is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Quetiapine. The risk or severity of adverse effects can be increased when Perindopril is combined with Olsalazine. The serum concentration of Alprazolam can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Tolmetin. The serum concentration of Naloxegol can be increased when it is combined with Perindopril. The risk or severity of adverse effects can be increased when Minoxidil is combined with Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Sacubitril. The risk or severity of adverse effects can be increased when Perindopril is combined with Bretylium. Udenafil may increase the antihypertensive activities of Perindopril. The risk or severity of adverse effects can be increased when Perindopril is combined with Guanfacine. The risk or severity of adverse effects can be increased when Ropinirole is combined with Perindopril. The risk or severity of adverse effects can be increased when Irbesartan is combined with Perindopril.